Close
New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse Jun 2, 2024 06:00PM
  • ‘Ultra-sensitive’ cancer blood test is highly accurate in identifying which breast cancer patients will relapse
  • The ‘Personalis NeXT Personal® liquid biopsy’ test uses whole genome sequencing to identify up to 1,800 mutations in a patient’s tumour DNA that can identify recurrence of the patient’s cancer from a blood sample
  • The median lead time from detection of disease to clinical relapse (shown on imaging) was 15 months – over three months... (continue reading...)

Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma Jun 2, 2024 05:30PM

Media Release

COPENHAGEN, Denmark; June 2, 2024

  • Preliminary analysis of data from the EPCORE™ NHL-2 study demonstrates patients with previously untreated follicular lymphoma (FL) who received epcoritamab in combination with rituximab-lenalidomide (R2) experienced a 95% overall response rate (ORR)
  • Results from the optimization cohort of the EPCORE™ NHL- 1 study show that mitigation strategies led to a clinically significant reduction in rate of cytokine release... (continue reading...)

Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year Jun 2, 2024 05:07PM

VALENCIA, Spain, June 02, 2024 (GLOBE NEWSWIRE) -- Allergic diseases cost between 1,823€ and 6,656€ per patient per year if we only consider the direct costs derived from healthcare, according to a study of the data collected through the European HEAD registry promoted by the EAACI, which is holding its congress at the Feria de Valencia until Monday, June 3.

“Allergic diseases and asthma are among the most common chronic diseases worldwide and account for a... (continue reading...)


FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations Jun 2, 2024 04:00PM

SAN FRANCISCO, June 2, 2024 /PRNewswire/ -- FrogData (www.frogdata.com), the trailblazer in data-driven decision-making solutions for automotive dealerships, today announced a significant upgrade to its pioneering Artificial Intelligence (AI) Factory. This enhancement introduces new solutions focused on Used Car Pricing, Service Management, and New Car Sales Negotiation, further empowering dealerships to optimize their operations and profitability.

... (continue reading...)
izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement Jun 2, 2024 03:45PM

SAN FRANCISCO, June 2, 2024 /PRNewswire/ -- izmostock (www.izmostock.com), a leader in automotive imagery with over twenty years of global experience, today announced the launch of its revolutionary solution tailored specifically for the operational leasing sector. This new offering is set to transform the digital landscape of automotive leasing by providing high-quality, standardized vehicle images essential for online platforms.

... (continue reading...)


More Press Releases

View Older Stories

Jun 2, 2024 03:30PM Summer Ready with Ulike Air 10: Your Smoothness Companion
Jun 2, 2024 04:07PM When Solar PV Meets Blockchain: Pse.USDT Leading the Green Energy Revolution
Jun 2, 2024 02:32PM TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Jun 2, 2024 12:40PM GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
Jun 2, 2024 12:30PM Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
Jun 2, 2024 12:30PM CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated
Jun 2, 2024 12:30PM Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
Jun 2, 2024 11:32AM Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:24AM Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
Jun 2, 2024 11:00AM Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
Jun 2, 2024 10:56AM Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
Jun 2, 2024 10:55AM Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Jun 2, 2024 10:45AM ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
Jun 2, 2024 10:40AM Boomco (BOOM) Is Now Available for Trading on LBank Exchange
Jun 2, 2024 10:25AM ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
Jun 2, 2024 10:01AM Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
Jun 2, 2024 10:00AM MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
Jun 2, 2024 10:00AM Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
Jun 2, 2024 10:00AM Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple
Jun 2, 2024 10:00AM ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
Jun 2, 2024 10:00AM Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 The
Jun 2, 2024 09:49AM The Curious Journey of Qurious Media Singapore: Revolutionizing Digital Marketing for Small Businesses
Jun 2, 2024 09:49AM GTS Nordic Expands with North Carolina Office to Meet Rising Demand for Compliant Employment Solutions in the United States
Jun 2, 2024 09:51AM BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 2, 2024 09:43AM Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
Jun 2, 2024 09:30AM Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
Jun 2, 2024 09:30AM Tempus Introduces New HER2 & FOLR1 Testing Solutions to Support Personalized Patient Care
Jun 2, 2024 09:10AM Hour One Enables Life-Like Cinematic Avatar of NVIDIA CEO Jensen Huang at Computex 2024
Jun 2, 2024 09:00AM Introducing Red Kale Medley, a Mix of Baby Red and Green Kale Complemented by B&W’s Signature Watercress
Jun 2, 2024 09:01AM Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024
Jun 2, 2024 09:00AM ZT Systems Announces ACX200 Solutions Featuring NVIDIA GB200 Grace Blackwell Superchips for Next-Generation Accelerated Computing
Jun 2, 2024 08:56AM NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan
Jun 2, 2024 08:52AM NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous Machines
Jun 2, 2024 08:44AM Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omniverse
Jun 2, 2024 08:42AM Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 2, 2024 08:41AM NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs
Jun 2, 2024 08:35AM Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
Jun 2, 2024 08:32AM NVIDIA Supercharges Ethernet Networking for Generative AI
Jun 2, 2024 08:30AM Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
Jun 2, 2024 08:30AM Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
Jun 2, 2024 08:30AM Vention to democratize industrial automation using NVIDIA AI technologies
Jun 2, 2024 08:30AM Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
Jun 2, 2024 08:23AM GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Jun 2, 2024 08:13AM NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
Jun 2, 2024 08:11AM NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
Jun 2, 2024 08:05AM IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
View Older Stories